HRT Financial’s CAMP4 Therapeutics CAMP Stock Holding History

HRT Financial’s Portfolio CAMP Stock Details CAMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,747	Closed	-$135K	–	4282
2026 Q1	$135K	Buy	+30,747	New	+$146K	﹤0.01%	3292

Other funds holding CAMP

Jupiter Topco New York $245B AUM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's CAMP Position: Q2 2026 in Review

HRT Financial sold out of CAMP4 Therapeutics (CAMP) in Q2 2026, closing a stake of 30,747 shares — an estimated $135K sold.

HRT Financial first reported a position in CAMP in Q1 2026 and held it in 1 quarter. The position peaked at $135K in Q1 2026. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

HRT Financial reported no remaining CAMP4 Therapeutics position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 30,747 CAMP4 Therapeutics shares in Q2 2026, an estimated $135K.
HRT Financial first reported a position in CAMP4 Therapeutics in Q1 2026 and held it in 1 quarter.
HRT Financial's CAMP4 Therapeutics position peaked at $135K in Q1 2026.
61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.